252 related articles for article (PubMed ID: 12052862)
1. Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter.
Benkoussa M; Brand C; Delmotte MH; Formstecher P; Lefebvre P
Mol Cell Biol; 2002 Jul; 22(13):4522-34. PubMed ID: 12052862
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
[TBL] [Abstract][Full Text] [Related]
3. Identification of the AP1-antagonism domain of retinoic acid receptors.
DiSepio D; Sutter M; Johnson AT; Chandraratna RA; Nagpal S
Mol Cell Biol Res Commun; 1999 Apr; 1(1):7-13. PubMed ID: 10329471
[TBL] [Abstract][Full Text] [Related]
4. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway.
Caelles C; González-Sancho JM; Muñoz A
Genes Dev; 1997 Dec; 11(24):3351-64. PubMed ID: 9407028
[TBL] [Abstract][Full Text] [Related]
5. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
[TBL] [Abstract][Full Text] [Related]
6. H11-H12 loop retinoic acid receptor mutants exhibit distinct trans-activating and trans-repressing activities in the presence of natural or synthetic retinoids.
Lefebvre B; Mouchon A; Formstecher P; Lefebvre P
Biochemistry; 1998 Jun; 37(26):9240-9. PubMed ID: 9649304
[TBL] [Abstract][Full Text] [Related]
7. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p38 MAP kinase increases okadaic acid mediated AP-1 expression and DNA binding but has no effect on TRE dependent transcription.
Rosenberger SF; Gupta A; Bowden GT
Oncogene; 1999 Jun; 18(24):3626-32. PubMed ID: 10380884
[TBL] [Abstract][Full Text] [Related]
9. IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner.
Si J; Collins SJ
Blood; 2002 Dec; 100(13):4401-9. PubMed ID: 12393611
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, AP1 signal transduction pathway.
Efimova T; LaCelle P; Welter JF; Eckert RL
J Biol Chem; 1998 Sep; 273(38):24387-95. PubMed ID: 9733728
[TBL] [Abstract][Full Text] [Related]
11. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
12. Selective stimulation by ceramide of the expression of the alpha isoform of retinoic acid and retinoid X receptors in osteoblastic cells. A role of sphingosine 1-phosphate-mediated AP-1 in the ligand-dependent transcriptional activity of these receptors.
Takeshita A; Watanabe A; Takada Y; Hanazawa S
J Biol Chem; 2000 Oct; 275(41):32220-6. PubMed ID: 10915783
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein phosphatase PP1 in GH3B6, but not in GH3 cells, activates the MEK/ERK/c-fos pathway and the human prolactin promoter, involving the coactivator CPB/p300.
Manfroid I; Martial JA; Muller M
Mol Endocrinol; 2001 Apr; 15(4):625-37. PubMed ID: 11266513
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.
Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ
J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: a potential role for trans-RA-induced ZBP-89 in ODC inhibition.
Dawson MI; Park JH; Chen G; Chao W; Dousman L; Waleh N; Hobbs PD; Jong L; Toll L; Zhang X; Gu J; Agadir A; Merchant JL; Bai L; Verma AK; Thacher SM; Chandraratna RA; Shroot B; Hill DL
Int J Cancer; 2001 Jan; 91(1):8-21. PubMed ID: 11149424
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid stimulation of the human surfactant protein B promoter is thyroid transcription factor 1 site-dependent.
Naltner A; Ghaffari M; Whitsett JA; Yan C
J Biol Chem; 2000 Jan; 275(1):56-62. PubMed ID: 10617585
[TBL] [Abstract][Full Text] [Related]
17. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
Dong S; Tweardy DJ
Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways.
Pestell RG; Albanese C; Watanabe G; Lee RJ; Lastowiecki P; Zon L; Ostrowski M; Jameson JL
Mol Endocrinol; 1996 Sep; 10(9):1084-94. PubMed ID: 8885243
[TBL] [Abstract][Full Text] [Related]
19. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
[TBL] [Abstract][Full Text] [Related]
20. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.
Chen JY; Penco S; Ostrowski J; Balaguer P; Pons M; Starrett JE; Reczek P; Chambon P; Gronemeyer H
EMBO J; 1995 Mar; 14(6):1187-97. PubMed ID: 7720709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
